Doç. Dr. Emir Çelik

The most cited articles on cancer immunotherapy: An update study.

PubMed, 2020

PMID 32521924 5 Zitationen (Europe PMC) Quelle: OpenAlex

Follicular lymphoma generating in a patient with non-small cell lung cancer following nivolumab discontinuation

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155220918627 PMID 32299317 1 Zitation (Europe PMC) Quelle: OpenAlex

Complete response after ceritinib treatment in non-small cell lung cancer in an elderly patient

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155220919172 PMID 32340536 1 Zitation (Europe PMC) Quelle: OpenAlex

KANSER HASTALARINDA UYKU KALİTESİNİ ETKİLEYEN FAKTÖRLER

Namık Kemal Tıp Dergisi, 2020

DOI 10.37696/nkmj.674879 Frei zugänglicher VolltextQuelle: OpenAlex

Classical versus non-classical EGFR mutations: Erlotinib response and impact of renal insufficiency

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155220964895 PMID 33040673 Quelle: OpenAlex

Optic Neuritis Related to Atezolizumab Treatment in a Patient With Metastatic Non–Small-Cell Lung Cancer

JCO Oncology Practice, 2019

DOI 10.1200/jop.19.00438 PMID 31721624 11 Zitationen (Europe PMC) Quelle: OpenAlex

Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience

Annals of Oncology, 2019

DOI 10.1093/annonc/mdz449.007 Frei zugänglicher VolltextQuelle: OpenAlex

Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-up

Endocrine, 2018

DOI 10.1007/s12020-018-1744-8 PMID 30206771 29 Zitationen (Europe PMC) Quelle: OpenAlex